Evidence that a synthetic amyloid-ß oligomer-binding peptide (ABP) targets amyloid-ß deposits in transgenic mouse brain and human Alzheimer's disease brain.
Biochemical and Biophysical Research Communications(2014)
摘要
•Aβ oligomers may play a key role in Alzheimer’s disease (AD) development.•Agents that neutralize or clear Aβ oligomers may delay or prevent AD development.•A short peptide derived from PCM-1 protein selectively binds Aβ oligomers in vitro.•Here we show that this amyloid binding peptide binds brain amyloid deposits in vivo.•Thus, oligomer-selective amyloid binding peptide (ABP) may be an AD therapeutic.
更多查看译文
关键词
Alzheimer’s disease,Aβ1–42 oligomers,AD transgenic mice,Human AD brains,PCM-1 protein,Amyloid binding peptide
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要